358 related articles for article (PubMed ID: 25712277)
1. An update on current prenatal testing options: first trimester and noninvasive prenatal testing.
Latendresse G; Deneris A
J Midwifery Womens Health; 2015; 60(1):24-36; quiz 111. PubMed ID: 25712277
[TBL] [Abstract][Full Text] [Related]
2. Use of the Combined First-Trimester Screen in High- and Low-Risk Patient Populations After Introduction of Noninvasive Prenatal Testing.
Larion S; Warsof SL; Romary L; Mlynarczyk M; Peleg D; Abuhamad AZ
J Ultrasound Med; 2015 Aug; 34(8):1423-8. PubMed ID: 26206828
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive prenatal testing for trisomy 21: challenges for implementation in Australia.
Hui L; Hyett J
Aust N Z J Obstet Gynaecol; 2013 Oct; 53(5):416-24. PubMed ID: 23902297
[TBL] [Abstract][Full Text] [Related]
4. Prenatal screening for Down syndrome in Australia: costs and benefits of current and novel screening strategies.
O'Leary P; Maxwell S; Murch A; Hendrie D
Aust N Z J Obstet Gynaecol; 2013 Oct; 53(5):425-33. PubMed ID: 24090461
[TBL] [Abstract][Full Text] [Related]
5. Options for Down syndrome screening: what will women choose?
Grant SS
J Midwifery Womens Health; 2005; 50(3):211-8. PubMed ID: 15894999
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive detection of fetal trisomy 21: systematic review and report of quality and outcomes of diagnostic accuracy studies performed between 1997 and 2012.
Mersy E; Smits LJ; van Winden LA; de Die-Smulders CE; ; Paulussen AD; Macville MV; Coumans AB; Frints SG
Hum Reprod Update; 2013; 19(4):318-29. PubMed ID: 23396607
[TBL] [Abstract][Full Text] [Related]
7. From Down syndrome screening to noninvasive prenatal testing: 20 years' experience in Taiwan.
Shaw SW; Chen CP; Cheng PJ
Taiwan J Obstet Gynecol; 2013 Dec; 52(4):470-4. PubMed ID: 24411028
[TBL] [Abstract][Full Text] [Related]
8. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
Spencer K; Nicolaides KH
BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive prenatal testing: more caution in counseling is needed in high risk pregnancies with ultrasound abnormalities.
Oneda B; Steindl K; Masood R; Reshetnikova I; Krejci P; Baldinger R; Reissmann R; Taralczak M; Guetg A; Wisser J; Fauchère JC; Rauch A
Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():72-5. PubMed ID: 26989803
[TBL] [Abstract][Full Text] [Related]
10. Second-trimester prenatal screening for trisomy 21 using biochemical markers: a 7-year experience in one cytogenetic laboratory.
Marical H; Douet-Guilbert N; Bages K; Collet M; Le Bris MJ; Morel F; De Braekeleer M
Prenat Diagn; 2006 Apr; 26(4):308-12. PubMed ID: 16491510
[TBL] [Abstract][Full Text] [Related]
11. Cost effectiveness, the economic considerations of prenatal screening strategies for trisomy 21 in the Czech Republic.
Dhaifalah I; Májek O
Ceska Gynekol; 2012 Feb; 77(1):39-51. PubMed ID: 22536640
[TBL] [Abstract][Full Text] [Related]
12. Current methods of prenatal screening for Down syndrome and other fetal abnormalities.
Saller DN; Canick JA
Clin Obstet Gynecol; 2008 Mar; 51(1):24-36. PubMed ID: 18303497
[TBL] [Abstract][Full Text] [Related]
13. Women's preference for non-invasive prenatal DNA testing versus chromosomal microarray after screening for Down syndrome: a prospective study.
Cheng Y; Leung WC; Leung TY; Choy KW; Chiu R; Lo TK; Kwok KY; Sahota DS
BJOG; 2018 Mar; 125(4):451-459. PubMed ID: 29125674
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive prenatal testing for fetal trisomy in a mixed risk factors pregnancy population.
Li WH; Wang PH; Chuang CM; Chang YW; Yang MJ; Chen CY; Chao KC; Yen MS
Taiwan J Obstet Gynecol; 2015 Apr; 54(2):122-5. PubMed ID: 25951714
[TBL] [Abstract][Full Text] [Related]
15. Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome.
Thilaganathan B; Slack A; Wathen NC
Ultrasound Obstet Gynecol; 1997 Oct; 10(4):261-4. PubMed ID: 9383877
[TBL] [Abstract][Full Text] [Related]
16. Incorporating first-trimester Down syndrome studies into prenatal screening: executive summary of the National Institute of Child Health and Human Development workshop.
Reddy UM; Mennuti MT
Obstet Gynecol; 2006 Jan; 107(1):167-73. PubMed ID: 16394055
[TBL] [Abstract][Full Text] [Related]
17. Patient-centered prenatal counseling: aligning obstetric healthcare professionals with needs of pregnant women.
Farrell RM; Nutter B; Agatisa PK
Women Health; 2015; 55(3):280-96. PubMed ID: 25794055
[TBL] [Abstract][Full Text] [Related]
18. Role of the second-trimester 'genetic sonogram' for Down syndrome screen in the era of first-trimester screening and noninvasive prenatal testing.
Odibo AO; Ghidini A
Prenat Diagn; 2014 Jun; 34(6):511-7. PubMed ID: 24436177
[TBL] [Abstract][Full Text] [Related]
19. Screening for Down syndrome using first-trimester ultrasound and second-trimester maternal serum markers in a low-risk population: a prospective longitudinal study.
Audibert F; Dommergues M; Benattar C; Taieb J; Thalabard JC; Frydman R
Ultrasound Obstet Gynecol; 2001 Jul; 18(1):26-31. PubMed ID: 11489221
[TBL] [Abstract][Full Text] [Related]
20. Prospective assessment of the Hong Kong Hospital Authority universal Down syndrome screening programme.
Sahota DS; Leung WC; Chan WP; To WW; Lau ET; Leung TY
Hong Kong Med J; 2013 Apr; 19(2):101-8. PubMed ID: 23535668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
